Slide 1: Kinaxis Q2 25 Results Conference Call
Kinaxis Q2 25 Results Conference Call BOB COURTEAU | INTERIM CEO AND CHAIR BLAINE FITZGERALD | CFO RICK WADSWORTH | VP, INVESTOR RELATIONS AUGUST 7, 2025
Slide 2: Forward-looking Statements and Other Disclosures
DISCLAIMER Forward-looking Statements and Other Disclosures FORWARD-LOOKING INFORMATION This presentation and webcast (the “presentation”) contains forward-looking statements within the meaning of applicable Canadian securities legislation. In some cases, these forward-looking statements can be iden
Slide 3: Forward-looking Statements and Other Disclosures
DISCLAIMER Forward-looking Statements and Other Disclosures ANNUAL RECURRING REVENUE (ARR) ARR is an industry metric used widely among SaaS businesses as a means of evaluating a company’s underlying operating performance. Securities analysts, investors and other interested parties also frequently us
Slide 4: 17% SaaS Growth, 25% Adj EBITDA Margin
Q2 HIGHLIGHTS 17% SaaS Growth, 25% Adj EBITDA Margin SaaS Revenue Total Revenue Adjusted EBITDA1 ARR3 YoY growth $88.4M $136.4M $33.7M 15% 17% Growth 15% Growth 25% Margin Constant Currency2 Constant Currency2 Constant Currency2 14% Growth 13% Growth 13% 1. See Slide 2, NON-IFRS FINANCIAL MEASURES S
Slide 5: Winning New and Expansion Business
ONGOING STRENGTH IN DEMAND Winning New and Sample customer wins Expansion Business Consumer Products Lactalis, McKee Foods, P&L Development -50% / 50% split in gross ARR added, new vs expansion business Life Sciences Swedish Orphan Biovitrum, Shimadzu -3 of 4 Gartner “Masters of Supply Chain” are Ki
Slide 6: AI-powered orchestration made easy
PRODUCT LEADERSHIP AI-powered orchestration made easy CONVERSATIONAL UX Simplify work and empower teams with an intuitive interface that uses scalable, no-code automation and AI to streamline processes and drive exception-based planning. ALWAYS-ON INTELLIGENCE ENGINE Accelerate results with an alway
Slide 7: Q2 Financial Results Summary
FINANCIAL RESULTS Q2 Financial Results Summary US$000 Q2 2025 Q2 2024 Change EXCEPT AS OTHERWISE INDICATED Total Revenue 136,415 118,278 15% Strong Q2 results Constant currency2 133,193 13% • 4th consecutive Rule of 40 quarter SaaS Revenue 88,437 75,395 17% Constant currency2 86,323 14% • SaaS growt
Slide 8: LTM FCF margin trend shows heightened focus on profitability
25% LTM FCF Margin Linear (LTM FCF Margin) OPERATING METRICS 19.7% LTM FCF margin trend 20% shows heightened focus on profitability 15% 15.1% 19.7% LTM FCF Margin 10% • One-time tax planning payment, 6.6% 8.8% litigation settlement from Q1 25 impacted LTM margin by 5.5 pp 5% 0% Slide 8 Copyright © 2
Slide 9: Annual Recurring Revenue
OPERATING METRICS $450 Annual Recurring $400 391 Revenue 1 $350 360 339 347 360 372 322 $300 15% YoY growth, 13% in CC US$ MILLIONS 274 $250 Second highest gross additions to ARR 221 $200 ever, outside of Q4 185 $150 Gross incremental ARR split $100 • NNA/Expansion : 50/50 $50 $0 FY '20 FY '21 FY '2
Slide 10: Strong RPO Growth
SaaS RPO Total RPO $900 OPERATING METRICS 833.9 Strong RPO Growth $800 748.4 793.3 $700 $834 million in total RPO 704.8 US$ MILLIONS 586.9 3-year CAGR $600 494.8 • Total revenue: 19% 542.5 $500 • SaaS revenue: 20% 459.6 $400 $300 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Q2 2022 2022 2022 2023 2023 2023 2
Slide 11: Updating 2025 Guidance
FY ‘25 GUIDANCE Updating 2025 Guidance Subscription Term Adjusted EBITDA Total Revenue SaaS Revenue Growth License Revenue Margin1 $535-550M 13-15% $16-18 million 23-25% Constant Currency2 Constant Currency2 $535-550M 13-15% Slide 11 Copyright © 2025 Kinaxis. All Rights Reserved. 1. See Slide 2, NON
Slide 12: Share Buyback Active
NORMAL COURSE ISSUER BID Share Buyback Active Repurchased 283,297 common shares in H1 2025 • Average price of US$125.85 • Plan expires November 5, 2025 • Up to 1.4 million shares (5% of outstanding) available for purchase • Maximum 15,500 shares allowed per day, subject to exceptions Slide 12 Copyri
Slide 13: Kinaxis - Powering the world's supply chains
KINAGXIS' >) Powering the world’s supply chains